Arava (Ah-RAY-va, leflunomide), a new disease-modifying drug for rheumatoid arthritis

October 1998

Hoechst is now shipping Arava (Ah-RAY-va, leflunomide), a new disease-modifying drug for rheumatoid arthritis.

Arava relieves pain and swelling...and slows joint damage. It works by inhibiting the production of immune cells that attack the joints.

It's as effective as methotrexate or sulfasalazine.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

lots of attention now on sports supplements
Arava (Ah-RAY-va, leflunomide), a new disease-modifying drug for rheumatoid arthritis
Diabetes intensive treatment of type 2 diabetes reduces complications
Infectious Diseases Cipro suspension
Infectious Diseases RotaShield, the first vaccine to prevent rotavirus infection in infants and young children
there's NO need to stop warfarin therapy before most dental surgery
lots of ads for new dental chewing gums
surprising link between chronic gum infection and other conditions
Gastroenterology Remicade (infliximab), a new biotech drug for Crohn's disease
Hematology & Oncology two significant new approaches for treating and preventing breast cancer
Hematology & Oncology Tamoxifen (Nolvadex) will be approved to PREVENT breast cancer
Hematology & Oncology selenium lowers the risk of prostate cancer
Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day
Women's Health calcium supplements can help relieve premenstrual syndrome (PMS)
Women's Health Preven Emergency Contraceptive Kit
Women's Health Some Washington pharmacists now provide emergency contraceptive pills (ECPs) to women
new precaution in the package insert of inhaled corticosteroids